Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_assertion type Assertion NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_head.
- NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_assertion description "[LZTS1 has been shown to have tumour suppressor activities against prostate and breast cancer and is located within a region of frequent loss of heterozygosity (LOH) at 8p22 in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_provenance.
- NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_assertion evidence source_evidence_literature NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_provenance.
- NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_assertion SIO_000772 15876481 NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_provenance.
- NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_assertion wasDerivedFrom befree-20150227 NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_provenance.
- NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_assertion wasGeneratedBy ECO_0000203 NP861509.RADvNUsMCRhyIwqiS7s91V72YrD-PrPS18TFVXNGT4w88130_provenance.